Skip to main content
GERN logo

Geron Corporation

GERNNASDAQHealthcareBiotechnology

$1.17Today:- (-)1Y +2.50%

As of Oct 16, 2026 close

Market cap
$824.96M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$1.04$2.01
Volume (live)
-
Avg. volume (3M)
8.97M

Geron (GERN) Income Statement

Geron reported revenue of $183.88M in fiscal 2025 (fiscal year ended Dec 31, 2025), up 138.8% from $76.99M a year earlier. Geron posted a net loss of $83.50M, compared with a net loss of $174.57M a year earlier. Gross margin was 97.4% and operating margin -28.0%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $57.48M, up 17.2% from the same quarter a year earlier.

Geron Income Statement Analysis

Values in millions USD

Scroll to see more
Geron Corporation income statement - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Revenue & Gross Profit
Revenue183.8876.990.240.601.390.250.461.071.07
Cost of Revenue4.75104.99125.050.0084.5350.0551.2712.728.44
Gross Profit179.1475.740.240.601.39-49.80-50.81-11.66-7.37
Operating Expenses
Research & Development71.43103.74125.0595.5285.7351.4952.0713.4311.03
Selling, General & Administrative159.26145.7369.1443.6330.8627.1121.6918.7119.29
Operating Expenses230.69249.47194.18139.15115.3927.1121.6932.1430.32
Operating Income-51.55-173.73-193.94-138.55-114.00-76.91-72.51-31.07-29.26
Other Income/Expense
Interest Income18.1219.6118.152.530.531.834.223.251.42
Interest Expense32.66-18.50-8.316.88-3.74-0.760.000.000.00
Other Income/Expense-17.41-0.849.821.00-2.110.173.964.061.34
Income
Income Before Tax-83.50-174.57-184.13-141.90-116.11-75.62-68.55-27.02-27.92
Income Tax Expense0.000.000.000.000.000.000.000.000.00
Net Income-83.50-174.57-184.13-141.90-116.11-75.62-68.55-27.02-27.92
Net Income - Continuous Operations-83.50-174.57-184.13-141.90-116.11-75.62-68.55-27.02-27.92
Net Income - Discontinued Operations---------
EBITDA-49.64-173.19-193.50-134.15-113.78-76.76-72.44-26.96-29.18
EBIT-50.84-173.73-193.94-135.02-114.00-76.91---
Depreciation & Amortization1.200.550.440.870.220.160.060.060.08
Earnings Per Share
Basic EPS---------
Diluted EPS---------
Basic Shares Outstanding666.66646.03570.65380.78327.63271.46190.16176.50159.22
Diluted Shares Outstanding666.66646.03570.65380.78327.63271.46190.16176.50159.22

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Geron Financial Statements

What was Geron's revenue in fiscal 2025?

Geron reported revenue of $183.88M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 138.8% from $76.99M a year earlier.

Is Geron profitable?

No. Geron reported a net loss of $83.50M in fiscal 2025. In fiscal 2024 it lost $174.57M.

What is Geron's operating margin?

Geron's operating income was −$51.55M on revenue of $183.88M in fiscal 2025, an operating margin of -28.0%, compared with -225.6% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition